Topics

First-In-US trial of CRISPR-edited immune cells for cancer appears safe

19:00 EST 5 Nov 2019 | AAAS

(University of Pennsylvania School of Medicine) Genetically editing a cancer patient's immune cells using CRISPR/Cas9 technology, then infusing those cells back into the patient appears safe and feasible based on early data from the first-ever clinical trial to test the approach in humans in the United States.

Original Article: First-In-US trial of CRISPR-edited immune cells for cancer appears safe

NEXT ARTICLE

More From BioPortfolio on "First-In-US trial of CRISPR-edited immune cells for cancer appears safe"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...